177 related articles for article (PubMed ID: 15015656)
41. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p.
Hashimoto N; Murakami M; Takahashi Y; Fujimoto M; Inazawa J; Mineura K
Cancer; 2003 May; 97(9):2254-61. PubMed ID: 12712480
[TBL] [Abstract][Full Text] [Related]
42. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
Born PW; Broholm H; Laursen H
Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
[TBL] [Abstract][Full Text] [Related]
43. Localization of the neuronal class III beta-tubulin in oligodendrogliomas: comparison with Ki-67 proliferative index and 1p/19q status.
Katsetos CD; Del Valle L; Geddes JF; Aldape K; Boyd JC; Legido A; Khalili K; Perentes E; Mörk SJ
J Neuropathol Exp Neurol; 2002 Apr; 61(4):307-20. PubMed ID: 11939586
[TBL] [Abstract][Full Text] [Related]
44. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
Bauman GS; Ino Y; Ueki K; Zlatescu MC; Fisher BJ; Macdonald DR; Stitt L; Louis DN; Cairncross JG
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):825-30. PubMed ID: 11020580
[TBL] [Abstract][Full Text] [Related]
45. Chromosome 1p and 19q evaluation in low-grade oligodendrogliomas: a descriptive study.
Molinari C; Iorio P; Medri L; Ballardini M; Guiducci G; Cremonini AM; Cerasoli S; Riccioni L; Faedi M; Mariani GA; Zoli W; Silvestrini R; Calistri D
Int J Mol Med; 2010 Jan; 25(1):145-51. PubMed ID: 19956913
[TBL] [Abstract][Full Text] [Related]
46. MR imaging characteristics of oligodendroglial tumors with assessment of 1p/19q deletion status.
Sherman JH; Prevedello DM; Shah L; Raghavan P; Pouratian N; Starke RM; Lopes MB; Shaffrey ME; Schiff D
Acta Neurochir (Wien); 2010 Nov; 152(11):1827-34. PubMed ID: 20711790
[TBL] [Abstract][Full Text] [Related]
47. Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion.
Hewer E; Beck J; Vassella E; Vajtai I
Neuropathology; 2014 Feb; 34(1):32-8. PubMed ID: 23711170
[TBL] [Abstract][Full Text] [Related]
48. Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.
Gladitz J; Klink B; Seifert M
Acta Neuropathol Commun; 2018 Jun; 6(1):49. PubMed ID: 29890994
[TBL] [Abstract][Full Text] [Related]
49. [Molecular biology of oligodendroglial tumors].
Laigle-Donadey F; Benouaich-Amiel A; Hoang-Xuan K; Sanson M
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):260-8. PubMed ID: 16292170
[TBL] [Abstract][Full Text] [Related]
50. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas.
Kitange G; Misra A; Law M; Passe S; Kollmeyer TM; Maurer M; Ballman K; Feuerstein BG; Jenkins RB
Genes Chromosomes Cancer; 2005 Jan; 42(1):68-77. PubMed ID: 15472895
[TBL] [Abstract][Full Text] [Related]
51. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay.
Nigro JM; Takahashi MA; Ginzinger DG; Law M; Passe S; Jenkins RB; Aldape K
Am J Pathol; 2001 Apr; 158(4):1253-62. PubMed ID: 11290543
[TBL] [Abstract][Full Text] [Related]
52. A new der(1;7)(q10;p10) leading to a singular 1p loss in a case of glioblastoma with oligodendroglioma component.
Gadji M; Crous-Tsanaclis AM; Mathieu D; Mai S; Fortin D; Drouin R
Neuropathology; 2014 Apr; 34(2):170-8. PubMed ID: 24118308
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of low-grade oligodendroglial tumors with a chemotherapy regimen of procarbazine, lomustine, and vincristine.
Stege EM; Kros JM; de Bruin HG; Enting RH; van Heuvel I; Looijenga LH; van der Rijt CD; Smitt PA; van den Bent MJ
Cancer; 2005 Feb; 103(4):802-9. PubMed ID: 15637687
[TBL] [Abstract][Full Text] [Related]
54. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.
Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW
Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321
[TBL] [Abstract][Full Text] [Related]
55. Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas.
Tong CY; Ng HK; Pang JC; Hu J; Hui AB; Poon WS
Histopathology; 2000 Aug; 37(2):160-5. PubMed ID: 10931240
[TBL] [Abstract][Full Text] [Related]
56. Bone Marrow Metastases from a 1p/19q Co-deleted Oligodendroglioma - A Case Report.
Demeulenaere M; Duerinck J; DU Four S; Fostier K; Michotte A; Neyns B
Anticancer Res; 2016 Aug; 36(8):4145-9. PubMed ID: 27466523
[TBL] [Abstract][Full Text] [Related]
57. Gliosarcoma arising from oligodendroglioma (Oligosarcoma): A case report with genetic analyses.
Tanaka S; Hitotsumatsu T; Sugita Y; Ishido K; Ito O; Hatae R; Akagi Y; Yoshimoto K; Iihara K
Pathol Int; 2018 Oct; 68(10):567-573. PubMed ID: 30246385
[TBL] [Abstract][Full Text] [Related]
58. [Study of loss of heterozygosity in oligodendroglial tumors by real-time quantitative polymerase chain reaction-based microsatellite analysis].
Zhang SK; Lu DH; Piao YS; Cai YN; Xu QZ
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):731-4. PubMed ID: 17374257
[TBL] [Abstract][Full Text] [Related]
59. Correlations between molecular profile and tumor location in Chinese patients with oligodendroglial tumors.
Huang L; Jiang T; Yuan F; Li GL; Liu EZ; Wang ZC
Clin Neurol Neurosurg; 2008 Dec; 110(10):1020-4. PubMed ID: 18845382
[TBL] [Abstract][Full Text] [Related]
60. Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors.
Husemann K; Wolter M; Büschges R; Boström J; Sabel M; Reifenberger G
J Neuropathol Exp Neurol; 1999 Oct; 58(10):1041-50. PubMed ID: 10515227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]